-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Emerging Vulnerabilities in Special Populations

Symposia: Scientific Workshop on Viruses in Hematology: Emerging Challenges and Therapeutic Vulnerabilities Program: Scientific Workshops
Friday, December 8, 2023: 2:43 PM-3:33 PM
Room 8 (San Diego Convention Center)
Moderator:
and Rayne Rouce, MD, Texas Children's Hospital
Disclosures:
Rouce: Pfizer: Consultancy; Novartis: Honoraria; Tessa Therapeutics: Research Funding.
Moderator Introduction

Rayne Rouce, MD

Texas Children's Hospital, Houston, TX
AIDS Related Central Nervous System Lymphomas – How Does Biology Inform Us?

Colm Keane, MD, PhD

The University of Queensland, Brisbane, AUS
Chronic Active Epstein-Barr Virus - Are Myeloid Derived Suppressor Cells the Key?

Alexander Glover, mbchb

University of Birmingham, Nottingham, United Kingdom
Epigenetic Reprogramming to Sensitize Immunologically Silent EBV+ Lymphomas

Lisa Giulino Roth, MD

Weill Cornell Medical College, New York, NY
Panel Discussion
Break
See more of: Scientific Workshop on Viruses in Hematology: Emerging Challenges and Therapeutic Vulnerabilities
See more of: Scientific Workshops
<< Previous Session | Next Session >>